Tuberculosis Vaccines Market Definition
Tuberculosis (TB) is a major and deadly disease caused by the tuberculosis bacteria, Mycobacterium Tuberculosis (Mtb). Bacille Calmette-Guérin (BCG) is the vaccine for TB. This vaccine is not widely used in the United States, but it is often given to infants and small children in other countries where TB is common. BCG does not always protect people from getting TB, however, it prevents some serious TB complications in children. TB is considered a poverty-related disease affecting the poorest countries. Apart from human suffering, TB causes an economic burden. According to the World Health Organisation (WHO), it is estimated that about a third of the world’s population is infected with Mtb. In 2017, 10 million people fell ill with TB and 1.6 million of these people died. The BCG vaccine reaches more than 80% of all newborn children and infants in countries where it is part of the national childhood immunization program.
The market study is broken down by Type (Immunotherapeutic Vaccines, Booster Vaccines and Others), by Application (Hospitals, Clinics and Others) and major geographies with country level splits.
Research Analyst at AMA estimates that Indians Players will contribute to the maximum growth of Global Tuberculosis Vaccines market throughout the predicted period.
Sanofi (France), Merck & Co. (United States), GreenSignal Bio Pharma (India), GlaxoSmithKline (United Kingdom), Japan BCG Laboratory (Japan), IDT Biologika (Germany), Taj Pharmaceuticals (India), AJ Pharma Holding (Malaysia), Serum Institute of India (India) and Statens Serum Institute (Denmark) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Intervax Ltd. (Canada).
AdvanceMarketAnalytics has segmented the market of Global Tuberculosis Vaccines market by Type, Application and Region.
On the basis of geography, the market of Tuberculosis Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Testing Type, the sub-segment i.e. Tuberculin Skin Test (TST) will boost the Tuberculosis Vaccines market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
The general manufacturing recommendations for manufacturing establishments are contained in WHO’s Good manufacturing practices. BCG is susceptible to sunlight. Therefore, the procedures for the preparation of the vaccine should be so designed that all cultures and vaccines are protected from direct sunlight and ultraviolet light at all stages of manufacture, testing, and storage until the vaccine is issued. The production culture medium should contain no substances known to cause toxic or allergic reactions in humans. The label, and/or the packaging insert in some countries, printed on or affixed to each container should show the volume and nature of the diluent.
- Highest Demand from Developing & Underdeveloped Nations
- Government Initiatives to Eradicate Tuberculosis
- Breakthrough Innovations to Improve the Efficacy of Vaccines
- Regulations to Ensure Quality, Efficacy & Safety of Vaccines
- Increased Investment Requirements for Mid & Late-Stage R&D & Manufacturing
Key Target AudienceTuberculosis Vaccine Manufacturer, Distributor & Supplier, Healthcare Industry, Government Bodies & Associations, Raw Material Supplier, End-User and Others
About ApproachThe research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase